A library of 33 compounds was screened for potentiation of the antibiotic FR 900098 against the Francisella tularensis surrogate Francisella novicida. From the screen a highly potent 2-oxazoline adjuvant was discovered capable of potentiating FR 900098 with a 1000-fold reduction in MIC against the Francisella sub-species F. novicida and F. philomiragia.
antibiotic potentiation against the commonly used Francisella tularensis surrogate Francisella novicida. 20 F. novicida is often used in place of F. tularensis since both are genetically similar but does not require special containment facilities. 21 Antibiotic resistance and alternative treatment options for F. tularensis are of great interest due to its history as a biological weapon, 22 extreme virulence, 23 and environmental persistance. 24 Herein, we report the construction of a small library of heterocyclic analogues capable of potentiating the phosphonic acid antibiotic FR 900098 against the Francisella sub-species F. novicida.
The lead compound (1a) was tested against F. novicida and reduced FR 900098's MIC 4-fold to 4 μg mL −1 . Oxazoline analogues were then prepared by reacting 2-bromoethylamine and various acid chlorides in the presence of TEA at reflux (Scheme 1). The first series of compounds synthesized were designed in order to investigate the effect that the alkyl tail length had on antibiotic potentiation. When the tail was removed entirely (R = H, 1b), no reduction in antibiotic MIC was observed (Figure 2) . Modification of the tail to methyl (1c), ethyl (1d), and propyl (1e) substituents similarly delivered compounds that were unable to potentiate FR 900098. Increasing the tail length by a methylene unit to a butyl chain (1f) increased antibiotic activity 4-fold and lowered the MIC to 4 μg mL −1 . Interestingly, further extension to hexyl (1g) resulted in a marked decrease in MIC to 0.0156 μg mL −1 a 1000-fold overall reduction. Extension of the tail to heptyl (1h) potentiated FR 900098 with an 8-fold reduction to an MIC of 2 μg mL −1 .
In order to synthesize the octyl and nonyl tails, 4-octyl (2i) and 4-nonylbenzoyl chloride (2j) needed to be synthesized due to lack of commercial availability. The acid chlorides were synthesized by esterification of 4-iodobenzoic acid (2a) in refluxing MeOH under acid catalysis (Scheme 2). The methyl ester (2b) was then subjected to Sonogashira coupling with 1-octyne or 1-nonyne, giving alkynes 2c and 2d, which were both hydrogenated with H 2 over Pd/C in THF. The esters were then hydrolyzed with LiOH in refluxing THF/H 2 O and upon acidification gave pure carboxylic acids 2g and 2h. The acids were subsequently converted to the acid chlorides by treatment with oxalyl chloride in CH 2 Cl 2 and a catalytic amount of DMF. Finally, the acid chlorides were cyclized to 1i and 1j via the approach outlined in Scheme 1. Testing of octyl (1i), nonyl (1j) and decyl (1k) tail lengths revealed an 8-fold reduction to an MIC of 2 μg mL −1 for 1i, but no MIC reduction was observed for 1j or 1k.
Aside from alkyl substituents other functionalities were explored to probe the oxazolines ability to potentiate the antibiotic FR 900098. Switching the phenyl core for the heterocyclic pyridinyl core (1l) resulted in no change in antibiotic MIC. Incorporation of a highly electron donating para -dimethyl amino group (1m) also yielded no change in MIC, likewise for a para -azo motif (1n). Replacing the phenyl ring with a polycyclic naphthyl ring (1o) was non-advantageous. The results were similar for strongly electron withdrawing fluorine atoms in 1p and 1q, also being disadvantageous to MIC reduction, as was the introduction of a meta -bromine (1r). A cinnamoyl derivative (1s) was synthesized which actually increased the MIC to 32 μg mL −1 . Interestingly, increasing the ring size of the oxazoline to a 6-membered derivative (1t) displayed modest activity, reducing the MIC 4-fold to 4 μg mL −1 .
At this point our studies revealed that enhanced activity was observed with alkyl chains of pentyl, hexyl, heptyl and octyl, while other substitutions of the phenyl ring were unsuccessful at potentiating antibiotic activity. The next series of analogues were designed in order to establish the oxazolines role in activity. In order to assess whether the oxazoline was required analogues of the pentyl and hexyl tails were synthesized with oxazole head groups. Arylation of oxazole was achieved by reacting 2 equivalents of oxazole with aryl bromides (3a and 4a) using Pd(OAc) 2 , KOH, and RuPhos in refluxing toluene (Scheme 3). 25 Neither of the oxidized derivatives 3b or 4b, showed any activity as compared to the more saturated oxazolines. Other heterocylic heads were heads incorporated into the oxazolines position by standard Suzuki coupling conditions. The pyrimidine (3c) analogue moderately potentiated FR 900098 with an MIC of 4 μg mL −1 , while the pyridine (4c) derivative was much more active lowering the MIC to 0.5 μg mL −1 a 32-fold MIC reduction. We next evaluated whether substitution of the oxazoline with a thiazoline or imidazoline was tolerated. Thiazolines were synthesized by treatment of acid chlorides 5a and 6a with NH 4 OH in MeOH affording primary amides 5b and 6b, which were dehydrated to nitriles by refluxing SOCl 2 (Scheme 4). Cyclization of the nitriles was performed with 2-aminoethanethiol to give thiazolines 5d and 6d, which reduced antibiotic MIC to 1 μg mL −1 and 2 μg mL −1 a 16-fold and 8-fold reduction overall, respectively. The imidazoline (7b) was synthesized by cyclization from 7a with ethylenediamine and oxidation with NBS (Scheme 5). 26 Further oxidation of 7b to the imidazole (7c) was carried out by treatment with PhI(OAc) 2 . 27 The imidazoline, however, abrogated activity as did the more oxidized imidazole analogue. This loss in activity for the imidazoline led us to investigate the completely saturated heterocycles 1,3-dioxolane (7d) and 1,3-thiolane (7e). Acetalization and thioacetalization was carried out under standard conditions using catalytic acid and azeotropic distillation. The completely saturated analogues were inactive. Next, we sought to test the unmasked version of 1g, the carboxylic acid (8) . The acid was produced by hydrolysis of 6a and was found to be unable to potentiate FR 900098 (Scheme 6). Increasing 8's lipophilicity by esterification with MeOH and catalytic acid failed to produce enhanced activity as the methyl ester (9) . Surprisingly, the previously synthesized 2-aminoimidazole (10) analogue actually increased the MIC to 32 μg mL −1 , which has previously been shown to lower the MIC of β-lactam antibiotics and colistin against other gram-negative bacteria. 28 A time kill curve was constructed for 1g to determine whether it was acting through a toxic or non-toxic mechanism. Analysis of the graph shows a slight delay in growth for compound containing samples as compared to strictly bacterial samples at the 4 h and 6 h time points (SI Figure 1) . After 6 h samples containing 1g began to grow at a similar rate as the control and growth became identical after 24 h. This result provides strong evidence that the oxazoline 1g is acting through a non-bactericidal mechanism.
After discovering a highly active adjuvant for potentiation of FR 900098 against F. novicida we sought to establish the effectiveness of 1g across other sub-species of the Francisella genus. Having previously succeeded in potentiating F. philomiragia with 1a we tested 1g against that bacterium as well. Oxazoline 1g was slightly less active than the original lead, lowering the antibiotic MIC to 32 μg mL −1 a 32-fold reduction.
In conclusion, a diverse library of heterocycles was constructed in order to investigate potentiation of the antibiotic FR 900098 against the F. tularensis surrogate F. novicida. The SAR study led to several highly active heterocycles based on the lead 2-oxazoline 1a that were able to potentiate FR 900098. The most potent adjuvant 1g reduced the MIC 1000-fold from 16 μg mL −1 to 0.0156 μg mL −1 . Given the lipophilic nature of 1g, coupled with the observation that activity falls off precipitously below 30 μM (data not shown), the mechanism of action driving FR 900098 potentiation by compound 1g most likely involves membrane permealization; however further studies are necessary to validate this. Colony count enumeration provides evidence that strongly suggests that it is acting through a nontoxic mechanism. Testing of 1g against F. philomiragia demonstrates 1g's ability to potentiate FR 900098 against multiple sub-species across the Francisella genus.
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